Mouse Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Protein

Este producto es parte de KDR - kinase insert domain receptor
Product Graph
208€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mouse Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx069651
tested applications
WB, SDS-PAGE

Description

Recombinant Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR) is a recombinant Mouse protein produced in a Prokaryotic expression system (E. coli).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Vascular Endothelial Growth Factor Receptor 2 / VEGFR2 (KDR)
Host
E. coli
Origin
Mouse
Conjugation
Unconjugated
Observed MW
Molecular Weight: Calculated MW: 32.4 kDa  Observed MW (SDS-PAGE): 34 kDa
Concentration: Prior to lyophilization: 50 µg/ml
Sequence Fragment: Asn46-Thr322
Tag: N-terminal His tag
Purity
> 90%
Size 1
10 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
500 µg
Form
Lyophilized Reconstitute in ddH2O to a concentration less than or equal to 0.1 mg/ml. Do not vortex.
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 5% Trehalose.
Availability
Shipped within 5-7 working days.
Storage
Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P35918
Alias
FLK1,CD309,VEGFR,VEGFR2,VEGFR-2,Protein-tyrosine kinase receptor flk-1,Fetal liver kinase 1,Vascular endothelial growth factor receptor 2
Background
Protein KDR
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

KDR, also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a critical protein in the regulation of angiogenesis and vascular development. This receptor tyrosine kinase (RTK) is encoded by the KDR gene located on chromosome 4q12 in humans. KDR is a member of the VEGF receptor family, which plays an essential role in the processes of vasculogenesis and angiogenesis by mediating the cellular responses to the vascular endothelial growth factor (VEGF). The VEGF family consists of several ligands, with VEGF-A being the primary ligand for KDR. KDR is predominantly expressed in endothelial cells, where it regulates vascular permeability, endothelial cell proliferation, migration, and survival. Due to its pivotal role in vascular biology, KDR has been extensively studied in the context of cancer, where angiogenesis is a crucial process for tumor growth and metastasis. KDR's involvement in pathological angiogenesis makes it a significant target for anti-angiogenic therapies in cancer treatment. Moreover, it has implications in other diseases characterized by abnormal vascular growth, such as age-related macular degeneration and rheumatoid arthritis.

Related Products

EH0329

Human VEGFR2/KDR(Vascular endothelial growth factor receptor 2) ELISA Kit

Ver Producto
EM1445

Mouse VEGFR-2/KDR(Vascuoar Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto
ERB0130

Rabbit VEGFR-2/KDR(Vascular Endothelial Growth Factor Receptor 2) ELISA Kit

Ver Producto